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SUMMARY Dermatological emergencies include a number of clinical 
conditions usually accompanied by systemic symptoms that can lead 
to life-threatening complications. 
From the broad spectrum of life-threatening dermatoses, three cases 
are presented: a case of febrile ulceronecrotic Mucha-Habermann dis-
ease (FUMHD), a case of pemphigus vulgaris mimicking Stevens-John-
son syndrome (SJS), and a case of toxic epidermal necrolysis (TEN). 
Those cases were considered extreme, and presented to illustrate the 
positive outcome of timely intensive dermatological care.  
An interdisciplinary approach is essential in the diagnosis, treatment, 
management, and follow up of patients with life-threatening derma-
toses. 
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InTRoDUCTIon
Dermatological emergencies include various 
generalized dermatoses that can cause disruption 
in the anatomy and physiology of the skin, leading 
to a number of complications known as “acute skin 
failure”, a fatal syndrome which fulfills the definition 
of an emergency “ - a risk perceived by a doctor or a 
patient to life, limb or the structure/function of an im-
portant organ of the body” (1,2). Prompt implemen-
tation of appropriate treatment for the various sys-
temic complications of life-threatening dermatoses 
is mandatory. Between January 2011 and November 
2012, 3,962 patients were admitted to the Clinic of 
which 129 (3.25%) required special therapeutic mea-
sures: 36 cases of pemphigus vulgaris (0.9%), 1 case 
of toxic epidermal necrolysis (0.02%), and 92 cases 
of angioedema (2.32%). The three most severe cas-
es of life-threatening dermatoses were selected for 
presentation: a case of febrile ulceronecrotic Mucha-
Habermann disease (FUMHD), a case of PV mimick-
ing SJS and a case of toxic epidermal necrolysis (TEN), 
in order to raise the awareness of the complexity of 
treating such cases by clinical dermatologists.
CASE REPoRTS
Case 1. A previously healthy 25-year-old male 
patient was admitted for a generalized eruption 
of erythemato-violaceous round-to-oval-shaped 
papular lesions, some of them coalescing in large 
polycyclic plaques. The disease had started 4 weeks 
earlier as erythematous macules, 10 days after the 
patient self-administrated tetracycline for a dental 
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abscess. Routine laboratory investigations revealed 
leukocytosis, neutrophilia, lymphopenia, monocy-
tosis, inflammatory syndrome, and highly increased 
levels of serum anti-hepatitis B (HB) antigen associ-
ated with low serum levels of hepatitis B virus (HBV) 
DNA. Bacteriological examination of the skin lesions 
indicated superinfection with E. coli and Enterobacter 
spp. The biopsy of a cutaneous lesion on the abdo-
men revealed spongiosis and parakeratosis of the 
epidermis with exocytosis of numerous lymphocytes 
and erythrocytes in the papillary dermis, associated 
with profound hematic and lympho-plasmocytic in-
flammatory infiltrate reaching the deeper portion of 
the dermis.
During the first 2 weeks of hospitalization, the 
patient developed daily febrile episodes in the 38.1-
39.5°C range, accompanied by a local burning sen-
sation. All blood cultures taken in the febrile period 
were sterile. After 7 days of hospitalization, the le-
sions became ulcero-necrotic and covered over 60% 
of the patient’s body surface, primarily in the inter-
triginous and flexor areas, with sparing of the mucous 
membranes (Figure 1a). The diagnosis of FUMHD was 
established and systemic treatment was started with 
prednisone 0.5 mg/kg, erythromycin and 2 grams cef-
tazidime per day each, and analgesics and antipyret-
ics. Topical treatment consisted of antiseptics, derma-
tocorticoids, antibiotics, and sterile greasy bandages 
for the intertriginous ulcerations. The patient was 
discharged from the hospital 6 weeks later: his cuta-
neous lesions gradually improved and slowly healed. 
At follow-up examinations performed after 1 and 6 
months, the patient was in good general condition, 
but developed numerous hypertrophic and keloid 
scars (Figure 1b). 
Case 2. A 43-year-old female patient was referred 
to our clinic for confluent erosive lesions covering 
70% of the skin surface (Figure 2a), painful oral ero-
sions, and impaired general condition, diagnosed as 
SJS. The patient denied having a history of significant 
diseases. The current disease had started 2 months 
ago, as painful erosions in the oral cavity with no im-
provement after a course of systemic antibiotics. One 
month after onset, a disseminated cutaneous erup-
tion appeared, composed of flaccid blisters that gave 
rise to extensive denuded bleeding surfaces located 
especially on the back of the trunk, upper chest, and 
periorificial areas. The clinical suspicion of paraneo-
plastic pemphigus was excluded by CT imaging. His-
topathology findings were suggestive of PV. Direct 
immunofluorescence demonstrated IgG and C3 posi-
tive staining in a network pattern (Figure 2b). Labo-
ratory investigations showed anemia, hypoprotein-
aemia, severe hypoalbuminemia (the lowest value 
1.1 g/dL; n.v.=3.4-4.8 g/dL), hypokalemia (the lowest 
value 1.85 mmol/L; n.v.=3.6-5.2 mmol/L), hypocal-
cemia, and inflammatory syndrome. Bacteriological 
examination of the skin lesions indicated superinfec-
tion with E. coli and Pseudomonas aeruginosa. One of 
the main therapeutic goals was the correction of fluid 
and electrolyte imbalances, but also treating the se-
vere hypoalbuminemia. This was achieved by work-
ing closely with intensive care physicians. The treat-
ment consisted of systemic corticosteroids (predni-
sone 2 mg/kg daily) with slow tapering of the dose. 
The introduction of azathioprine as a corticosteroid-
sparing agent was not possible because the patient 
developed  high fever. Broad spectrum antibiotics 
(ertapenem, teicoplanin, and colistin) were adminis-
tered for the infection of the cutaneous lesions. Local 
Figure 1. (a) Multiple prominent ulcero-necrotic lesions in the intertriginous areas. (b) Numerous hypertrophic 
and keloid scars at time of follow-up visit after 6 months.
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treatment consisted of antiseptics, antibiotics, and 
dermatocorticoids. Disease course during hospitaliza-
tion was slowly favorable. The patient was discharged 
after 2 months of treatment, with cutaneous lesions 
having been almost completely reepithelized. At a 
follow-up visit after 1 year, the patient was in good 
general condition, with discrete hyperpigmented 
macular lesions on the trunk. 
Case 3. A 52-year-old patient was referred to our 
clinic for a cutaneous eruption consisting of blisters 
and erosions covered by hematic crusts, distributed 
over the entire surface of the skin (Fig 3). He also had 
mucosal involvement of the palate, gingiva, tongue, 
and genital area. There was conjunctival hyperemia, 
abundant conjunctival secretion, photophobia, and 
ocular foreign body sensation. The eruption started 
on the face 3 days prior to admission. The patient 
had been diagnosed with bipolar affective disorder 
2 years ago, and had been treated with lorazepam, 
valproic acid, olanzapine, and lamotrigine. The last 
two drugs were introduced two weeks before the 
onset of the eruption. Considering the sudden onset, 
disease course, fever, drug intake, and the body sur-
face involved (over 60%), the diagnosis of TEN was es-
tablished. The general treatment measures included: 
drugs discontinuation, blister puncture, removal of 
secretions, and daily local dressings. The treatment 
consisted of systemic corticotherapy and antibio-
therapy, electrolytes replacement, parenteral nutri-
tion, antihistamines, topical treatment with antiseptic 
solutions, and antibiotics. We also used artificial tears 
and eyewashes with antibiotics to treat corneal dam-
age. After 3 weeks of hospitalization, the denuded ar-
eas where replaced by postlesional hyperpigmenta-
tions and few hematic crusts. During hospitalization, 
the patient had an unsuccessful suicide attempt. 
DISCUSSIon
FUMHD is a rare and sometimes lethal form (mor-
tality 25%) of pityriasis lichenoides and varioliformis 
acuta, characterized by the dominance of necrotic 
skin lesions and high fever as well as other systemic 
symptoms, such as abdominal pain, arthritis, pulmo-
nary, and central nervous system involvement (3,4). A 
recent review described 41 cases of FUMHD treated 
with different therapeutic agents (5). While the etiol-
ogy of the disease remains unknown, one of the hy-
pothesis proposes the idea that FUMHD is a hyper-
sensitivity reaction after an infection (4,5). Problems 
encountered during patient hospitalization were: 
daily febrile episodes accompanied by severe burning 
sensation in skin lesions during the first two weeks, 
slowly improved by antipyretic treatment, large areas 
of ulceration in the folds at high risk of infection, and 
the association with newly diagnosed hepatitis B, a 
possible trigger for the disease. Under the course of 
systemic corticosteroids, erythromycin, and a careful 
local therapy, disease evolution was favorable. The 
patient became afebrile after the first two weeks, and 
was discharged after two months with cutaneous le-
sions partially reepithelialized.
PV can be a life-threatening autoimmune blis-
tering disorder, with a mortality of 5-15%, in which 
extensive skin and mucosal lesions result in the fail-
ure of main skin functions, in particular the defense 
against infections (6). The major cause of death in 
these patients are severe infections, including septi-
cemia, pneumonia, and cardiovascular disorder. The 
aim of the treatment is to stop the production of auto 
antibodies by administering corticosteroids, immu-
nosuppressants, and, more recently, biologics such as 
rituximab (7).
Figure 2. (a) Large erosive areas in a patient with PV. (b) Direct immunofluorescence positive for IgG in a net-
work pattern. 
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TEN is a life-threatening disease with sudden onset 
presenting as large epidermal denudation and mu-
cosal involvement (8). The trigger is almost always a 
drug, and the affected cutaneous area is greater than 
30%. Lamotrigine is a high risk drug in terms of TEN 
onset. The time between initial drug intake and the 
lesions onset is between 1 and 3 weeks (9). TEN can 
produce a great number of complications even when 
adequate  treatment is implemented, and mortality 
may reach 30-40% (10). The patient presented in case 
3 developed corneal damage with a risk of blinding. 
When TEN occurs due to psychiatric medication, the 
patient must be closely supervised and the causative 
medication discontinued. Systemic steroids can also 
induce psychiatric symptoms even at low doses (11).
For the presented cases, treatment priority was 
the correction and maintenance of haemodynamic 
equilibrium and electrolite balance by fluid and elec-
trolyte replacement. Hypoalbuminemia caused by 
extensive areas of denuded skin was also addressed 
by creating a positive balance of nitrogen by enteral 
proteic nutrition and by treating the inflammatory 
syndrome. In order to compensate for the hypercat-
abolic state and to promote tissue healing, massive 
nutritional support was provided. With regard to sep-
sis, the suprainfection of the skin lesions imposed the 
introduction of broad spectrum antibiotics. 
ConClUSIon
Life threatening dermatoses can frequent occur in 
a dermatologists’ office. Many cases present immedi-
ate type reactions (eg. anaphylaxis, angioedema) or 
severe and acute bacterial, viral, fungal, or parasitic 
infections. In some severe cases, as those described in 
this paper, well-equipped units must provide optimal 
conditions for supportive care (fluid, electrolyte, and 
nutritional replacement), allowing patients to receive 
complex medical care tailored to disease severity.
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Figure 3. Erosions covered by hematic crusts on the entire surface of the face. 
Figure 3. Erosions covered by hematic crusts on the 
entire surface of the face.
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